Vancomycin-resistant Staphylococcus aureus
GPTKB entity
Statements (39)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Bacteria
antibiotic-resistant organism |
| gptkbp:abbreviation |
gptkb:VRSA
|
| gptkbp:antibioticResistance |
altered cell wall precursors
reduced vancomycin binding |
| gptkbp:biosafetyLevel |
2
|
| gptkbp:cause |
gptkb:pneumonia
endocarditis osteomyelitis wound infections bacteremia community-acquired infections hospital-acquired infections |
| gptkbp:firstReported |
1997
|
| gptkbp:foundIn |
hospitals
healthcare settings |
| gptkbp:geneticMechanism |
horizontal gene transfer
acquisition of vanA gene |
| gptkbp:genomeType |
circular DNA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vancomycin-resistant Staphylococcus aureus
|
| gptkbp:monitors |
gptkb:Centers_for_Disease_Control_and_Prevention
|
| gptkbp:parent |
gptkb:Staphylococcus_aureus
|
| gptkbp:prevention |
hand hygiene
antibiotic stewardship infection control measures |
| gptkbp:publicHealthConcern |
yes
|
| gptkbp:relatedTo |
gptkb:methicillin-resistant_Staphylococcus_aureus
|
| gptkbp:resistantTo |
vancomycin
glycopeptide antibiotics |
| gptkbp:riskFactor |
chronic illness
immunosuppression prolonged antibiotic use |
| gptkbp:transmittedBy |
direct contact
contaminated surfaces |
| gptkbp:treatment |
gptkb:daptomycin
gptkb:linezolid quinupristin/dalfopristin |
| gptkbp:bfsParent |
gptkb:VRSA
|
| gptkbp:bfsLayer |
7
|